Home > Income Statement > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
AD     Remove this Ad

SUVEN PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹300 Cr₹41,129 Cr₹454 Cr₹362 Cr₹317 Cr

What is the latest Consolidated Net Profit of SUVEN PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of SUVEN PHARMACEUTICALS is ₹300 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹300 Cr
Mar2024₹41,129 Cr
Mar2023₹454 Cr
Mar2022₹362 Cr
Mar2021₹317 Cr

How is Consolidated Net Profit of SUVEN PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹300 Cr
-99.27
Mar2024 ₹41,129 Cr
8,963.15
Mar2023 ₹454 Cr
25.24
Mar2022 ₹362 Cr
14.30
Mar2021 ₹317 Cr -

Compare Consolidated Net Profit of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹13,526.8 Cr -3.6% -25.6% -69.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,698.0 Cr 0.2% -1.3% -3.5% Stock Analytics
DIVIS LABORATORIES ₹163,866.0 Cr 1.9% -6.7% 0.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,062.0 Cr 1.3% 2.9% 28.7% Stock Analytics
CIPLA ₹108,412.0 Cr 1.3% -8.5% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,805.0 Cr 1.3% 3.8% 4.5% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

-3.6%

-25.6%

-69.3%

SENSEX

0.6%

0.1%

9.2%


You may also like the below Video Courses